Still no participant
Still no reviews
CO | Statement | Mapping with POs |
1 | To understand the basic concepts in biopharmaceutics and pharmacokinetics and their significance | PO1, PO2.PO10 |
2 | To use of plasma drug concentration-time data to calculate the pharmacokinetic parameters to describe the kinetics of drug absorption, distribution, metabolism, excretion, elimination | PO1, PO2, PO10, PO11 |
3 | To understand the concepts of bioavailability and bioequivalence of drug products and their significance. | PO1, PO2,PO10 |
4 | To understand various pharmacokinetic parameters, their significance & applications | PO1, PO2, PO06 PO10 |
5 | Employable skills and high technical competence for Pharmaceutical Industry | PO1, PO2.PO11 |
Absorption; Mechanisms of drug absorption through GIT, factors influencing drug absorption though GIT, absorption of drug from Non per oral extra-vascular routes, Distribution Tissue permeability of drugs, binding of drugs, apparent, volume of drug distribution, plasma and tissue protein binding of drugs, factors affecting protein-drug binding. Kinetics of protein binding, Clinical significance of protein binding of drugs
Elimination: Drug metabolism and basic understanding metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs, renal clearance, Nonrenal routes of drug excretion of drugs
Bioavailability and Bioequivalence: Definition and Objectives of bioavailability, absolute and relative bioavailability, measurement of bioavailability, in-vitro drug dissolution models, in-vitro-in-vivo correlations, bioequivalence studies, methods to enhance the dissolution rates and bioavailability of poorly soluble drugs.
Pharmacokinetics: Definition and introduction to Pharmacokinetics, Compartment models, Noncompartment models, physiological models, One compartment open model. (a). Intravenous Injection (Bolus) (b). Intravenous infusion and (c) Extravascular administrations. Pharmacokinetics parameters - KE ,t1/2,Vd,AUC,Ka, Clt and CLR- definitions methods of eliminations, understanding of their significance and application
Multicompartment models: Two compartment open model. IV bolus
Kinetics of multiple dosing, steady state drug levels, calculation of loading and mainetnance doses and their significance in clinical settins.
Nonlinear Pharmacokinetics: a. Introduction, b. Factors causing Non-linearity. Michaelis-menton method of estimating parameters, Explanation with example of drugs.
Introduction to Biopharmaceutics: Absorption; Mechanisms of drug absorption through GIT
Absorption of drug from Non per oral extra-vascular routes
Clinical significance of protein binding of drugs
Elimination: Drug metabolism and basic understanding metabolic pathways renal excretion of drugs
Factors affecting renal excretion of drugs, renal clearance
Bioavailability and Bioequivalence: Definition and Objectives of bioavailability
Methods to enhance the dissolution rates and bioavailability of poorly soluble drugs |
One compartment open model (a) Intravenous Injection (Bolus) (b) Intravenous infusion and (c) Extra vascular administrations
Michaelis-menton method of estimating parameters, Explanation with example of drugs
M. Pharm (Pharmaceutics)